Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

Mary Anne DOOLEY; David JAYNE; Neil SOLOMONS; Ellen M GINZLER; David ISENBERG; NancyJ OLSEN; David WOFSY; Frank EITNER; Gerald B APPEL; Gabriel CONTRERAS; Laura LISK

doi:10.1056/NEJMoa1014460

Back

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

Journal article

Open access

Peer reviewed

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

Mary Anne DOOLEY, David JAYNE, Neil SOLOMONS, Ellen M GINZLER, David ISENBERG, NancyJ OLSEN, David WOFSY, Frank EITNER, Gerald B APPEL, Gabriel CONTRERAS, …

The New England journal of medicine, Vol.365(20), pp.1886-1895

2011

DOI: https://doi.org/10.1056/NEJMoa1014460

PMID: 22087680

Abstract

Antiviral agents

General aspects

Kidneys

Urinary system involvement in other diseases. Miscellaneous

Pharmacology. Drug treatments

Nephrology. Urinary tract diseases

Biological and medical sciences

Medical sciences

Antibiotics. Antiinfectious agents. Antiparasitic agents

Files and links (1)

url

https://doi.org/10.1056/NEJMoa1014460View

Published (Version of record) Open

Metrics

11 Record Views

426 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.106 Rheumatology; 1.106.478 Systemic Lupus Erythematosus
Web Of Science research areas: Urology & Nephrology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Creators: Mary Anne DOOLEY - Department of Medicine, University of North Carolina, Chapel Hill, United States
David JAYNE - Renal Unit, Addenbrooke's Hospital, Cambridge, United Kingdom
Neil SOLOMONS - Clinical Department, Vifor Pharma (formerly Aspreva Pharmaceuticals), Victoria, Canada
Ellen M GINZLER - Division of Rheumatology, State University of New York Downstate Medical Center, Brooklyn, United Kingdom
David ISENBERG - Department of Medicine, University College, London, United Kingdom
NancyJ OLSEN - Division of Rheumatology, Penn State Milton S. Hershey Medical Center, Hershey, PA, United States
David WOFSY - Division of Rheumatology and Rosalind Russell Medical Research Center, University of California, San Francisco, United States
Frank EITNER - Division of Nephrology and Immunology, Rheinisch―Westfälische Technische Hochschule, Aachen University, Aachen, Germany
Gerald B APPEL - Department of Nephrology, Columbia University, New York, United States
Gabriel CONTRERAS - Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, United States
Laura LISK - Vifor Pharma, Bagshot Park, Bagshot, Surrey, United Kingdom
Publication Details: The New England journal of medicine, Vol.365(20), pp.1886-1895
Publisher: Massachusetts Medical Society; Waltham, MA
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Nephrology & Hypertension Div
Language: English
Resource Type: Journal article
PMID: 22087680
Record Identifier: 991031559551602976